This is the authors' abstract. We don't add key points for this paper.
Dopa-responsive dystonia (DRD) is an autosomal dominant neurologic disorder characterized by incomplete penetrance and high variability of its phenotypic expression.1 The usual phenotype is defined by early-onset isolated dystonia, predominant in the lower limb, with marked diurnal fluctuations and a dramatic and sustained response to low doses of l-DOPA.2 We report 2 members of the same family (mother and daughter) with a nonsense heterozygous mutation ( c.706G>T; p.Glu236* ) in the GCH1 gene and having DRD with phenotypic variability.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Krim et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: